Free Trial

Biogen (BIIB) News Today

$225.43
-6.56 (-2.83%)
(As of 06/7/2024 08:51 PM ET)
Wedbush Comments on Biogen Inc.'s FY2027 Earnings (NASDAQ:BIIB)
Ossiam Sells 4,746 Shares of Biogen Inc. (NASDAQ:BIIB)
Ossiam trimmed its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,620 shares of the biotechnology company's stock after selling 4,746 shares
Epoch Investment Partners Inc. Has $71.74 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)
Epoch Investment Partners Inc. lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 49.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 277,224 shares of the biotechnology company's stock after pu
Pinebridge Investments L.P. Has $5.20 Million Holdings in Biogen Inc. (NASDAQ:BIIB)
Pinebridge Investments L.P. grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 51.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,104 shares of the biotechnolo
Cibc World Markets Corp Raises Stock Position in Biogen Inc. (NASDAQ:BIIB)
Cibc World Markets Corp increased its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 60.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,452 shares of the biotechnology company's stock after pu
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Armistice Capital LLC
Armistice Capital LLC lessened its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 27.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 200,000 shares of the biotech
Royal Bank of Canada Reiterates "Outperform" Rating for Biogen (NASDAQ:BIIB)
Royal Bank of Canada reaffirmed an "outperform" rating and set a $317.00 price objective on shares of Biogen in a report on Wednesday.
Carmignac Gestion Increases Holdings in Biogen Inc. (NASDAQ:BIIB)
Carmignac Gestion increased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 16.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 361,395 shares of the biotechnology company's stock after acquiring an additional 52,295 sh
Biogen Inc. (NASDAQ:BIIB) Short Interest Up 10.5% in May
Biogen Inc. (NASDAQ:BIIB - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 3,480,000 shares, a growth of 10.5% from the April 30th total of 3,150,000 shares. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is currently 2.9 days. Approximately 2.4% of the company's shares are short sold.
Bank of Nova Scotia Purchases 130,169 Shares of Biogen Inc. (NASDAQ:BIIB)
Bank of Nova Scotia lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 432.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 160,263 shares of the biotechnology company's stock a
Evoke Wealth LLC Invests $2.81 Million in Biogen Inc. (NASDAQ:BIIB)
Evoke Wealth LLC bought a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 10,851 shares of the biotechnology company's stock, valued at approxima
Treasurer of the State of North Carolina Buys 3,609 Shares of Biogen Inc. (NASDAQ:BIIB)
Treasurer of the State of North Carolina grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 95,852 shares of the biotechnology company's stock after acquiring an additiona
BIIB Jun 2024 350.000 put
Biogen (NASDAQ:BIIB) Receives Outperform Rating from Royal Bank of Canada
Royal Bank of Canada restated an "outperform" rating and issued a $317.00 price objective on shares of Biogen in a report on Wednesday.
BIIB Jan 2026 120.000 call

BIIB Media Mentions By Week

BIIB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIIB
News Sentiment

0.17

0.76

Average
Medical
News Sentiment

BIIB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIIB Articles
This Week

30

17

BIIB Articles
Average Week

Get Biogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BIIB) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners